Table 1 Characteristics of patients hospitalized for acute exacerbation of chronic pulmonary obstructive disease, according to aspirin use

From: The association of aspirin use with severity of acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study

 

Aspirin users

Non-users

 

Characteristics

n = 13,826

n = 192,860

P-value

Age, year, median (interquartile range)

73 (65–81)

70 (59–79)

<0.001

Female sex

7229 (52)

112,549 (58)

<0.001

Race/ethnicity

  

<0.001

Non-Hispanic white

11,528 (86)

139,497 (75)

 

Non-Hispanic black

867 (6)

19,134 (10)

 

Hispanics

716 (5)

18,996 (10)

 

Others

366 (3)

7250 (4)

 

Payer

  

<0.001

Medicare

10,835 (78)

135,143 (70)

 

Medicaid

902 (7)

21,012 (11)

 

Private

1474 (11)

22,843 (12)

 

Self-pay

238 (2)

7738 (4)

 

Others

377 (3)

6116 (3)

 

Quartiles for median household income

  

<0.001

1 (lowest)

3958 (29)

61,225 (33)

 

2

4147 (31)

52,084 (28)

 

3

3144 (23)

43,354 (23)

 

4 (highest)

2333 (17)

30,680 (16)

 

Number of comorbidities

  

<0.001

0–1

433 (3)

14,728 (8)

 

2–3

4173 (30)

74,140 (38)

 

≥4

9220 (67)

103,992 (54)

 

Selected comorbidities

   

Coronary artery diseases

6974 (50)

55,723 (29)

<0.001

Ischemic stroke

273 (3)

1821 (1)

<0.001

Hospital state

  

<0.001

Arkansas

1006 (7)

13,008 (7)

 

Florida

6085 (44)

90,530 (47)

 

Iowa

594 (4)

9431 (5)

 

Nebraska

114 (1)

5512 (3)

 

New York

3695 (27)

58,240 (30)

 

Utah

76 (1)

2757 (1)

 

Washington

2256 (16)

13,382 (7)

 
  1. Note: Data were shown as n (%) unless otherwise specified